Saturday 17 October 2026
Export ICCT’s income statement to Excel — free account
iCoreConnect Inc.
ICCT Healthcare Health Information Services
iCoreConnect Inc.’s revenue for fiscal 2024 (year ended December 2024) was $10.7 million, up 31.8% from fiscal 2023. In the quarter to December 2024, revenue fell 12.4%, EPS grew 92.5% and free cash flow grew 91.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
0.00
0.00
NaN
Follow ICCT
| Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | |
|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 4 | — | — | — | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.15 | 0.17 |
Altman Z-Score |
(70.71) | 257.02 | (21.36) | — | (18.92) | (11.83) | (45.87) |
Altman Z″-Score (non-manufacturers) |
(168.01) | (117.46) | (118.06) | — | (52.12) | (30.14) | (116.86) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | (3.76) | (6.02) | — | — | (4.15) | (26.03) |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | 55.35 | (1.32) | (0.92) |
P/B ratio |
3.34 | 3.34 | 3.34 | 3.34 | 0.00 | 2.10 | 0.00 |
Price to Tangible BV |
3.34 | 3.34 | 3.34 | 3.34 | 0.00 | 3.15 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.17 | 0.33 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | (18.49) | (1.08) | (1.11) |
EV/FCF |
0.00 | 0.00 | 0.00 | 0.00 | (18.49) | (0.98) | (1.24) |
Quick Ratio |
0.09 | 0.28 | 0.04 | 212.36 | 0.09 | 0.20 | 0.08 |
Current Ratio |
0.09 | 0.29 | 0.05 | 307.00 | 0.16 | 0.40 | 0.10 |
Net Debt/EBITDA |
(0.68) | (0.18) | (0.67) | (832.78) | (0.36) | (0.02) | (0.14) |
Debt/Assets |
110.32% | 37.59% | 58.71% | 0.00% | 22.11% | 9.05% | 34.76% |
Debt/Equity |
(2.00) | 2.04 | (2.51) | (476.00) | (0.58) | 0.32 | (0.20) |
Asset Turnover |
0.00 | 0.48 | 0.81 | 3.68 | 1.73 | 0.73 | 1.01 |
Operating CF/Net income |
0.38 | 0.56 | 0.36 | 0.00 | 0.16 | 0.55 | 0.10 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | (0.23) | (0.67) | 0.11 |
Interest Coverage |
(27.74) | (28.64) | (27.12) | — | (6.11) | (9.26) | (10.86) |
| 0.00% | 1,210.14% | 4,260.16% | 0.57% | 628.75% | (1,639.33%) | 1,240.88% | |
| 0.00% | (140.15%) | (133.95%) | (0.13%) | (170.32%) | (143.15%) | (310.62%) | |
ROIC |
0.00% | 0.00% | 0.00% | (0.08%) | 0.00% | (138.28%) | 0.00% |
Return on Tangible Assets |
227.83% | 225.47% | 139.17% | (0.15%) | 139.79% | 308.20% | 299.71% |
Average Days of Receivables |
75.08 | 36.36 | 21.74 | 46.32 | 18.95 | 25.25 | 27.65 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
316.90% | 338.66% | 162.32% | 0.04% | 115.86% | 185.54% | 193.13% |
Intangible Assets out of Total Assets |
0.86 | 0.76 | 0.75 | 0.00 | 0.23 | 0.09 | 0.26 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 21.50% | 23.82% | 66.39% |
Graham Net Nets |
(19.36) | (19.36) | (19.36) | (19.36) | (0.36) | (0.83) | (7.89) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 64.14 | 0.00 | 117.98 |
Earnings Yield |
(27.27%) | (27.27%) | (27.27%) | (27.27%) | (27.27%) | (169.49%) | (1,832.21%) |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | (5.71%) | (103.74%) | (159.96%) |
Revenue per Share |
0.73 | 0.52 | 0.83 | 1.01 | 27.70 | 22.18 | 14.82 |
Operating CF per Share |
(1.32) | (0.85) | (0.50) | 0.00 | (4.41) | (24.01) | (4.45) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (1.02) | (2.34) | 0.46 |
Free Cash Flow per Share |
(1.32) | (0.85) | (0.50) | 0.00 | (5.43) | (26.35) | (4.00) |
Cash per Share |
0.00 | 0.23 | 0.00 | 0.01 | 0.68 | 3.32 | 0.28 |
Shareholders Equity per Share |
(0.64) | 0.24 | (0.25) | 0.00 | (8.67) | 12.09 | (13.51) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.64) | 0.24 | (0.25) | 0.00 | (8.67) | 12.09 | (13.51) |
Free Cash Flow |
(1.97) | (1.67) | (1.27) | 0.00 | (1.57) | (9.68) | (2.90) |
Working Capital |
(2.29) | (1.38) | (3.03) | 1.01 | (5.71) | (5.37) | (11.25) |
Capital Expenditures |
(0.34) | (0.47) | (0.54) | 0.00 | (0.29) | (0.86) | 0.33 |
Net Current Asset Value |
(2.46) | (1.50) | (3.17) | 1.01 | (7.97) | (7.73) | (14.30) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.11 | (0.03) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||
Depreciation/Fixed assets |
37.00 | 11.10 | 1.73 | 0.00 | 17.41 | 6.30 | 17.30 |
Cash ROIC |
(205.75%) | (89.72%) | (132.56%) | 0.00% | 183.06% | (136.71%) | 38.09% |
Accounts Receivable Turnover |
0.00 | 6.24 | 18.67 | 13.12 | 15.31 | 16.66 | 15.60 |
Accounts Payable Turnover |
0.00 | 1.15 | 1.44 | 3.61 | 1.92 | 0.73 | 0.62 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
283.13 | 380.59 | 317.19 | 0.40 | 380.12 | 583.41 | 697.38 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 0.16 | 0.11 | 0.38 | 0.52 | 0.49 | 0.69 |
Average Payables |
— | 0.83 | 1.33 | 0.83 | 1.17 | 2.79 | 4.01 |
Average Assets |
— | 2.13 | 2.61 | 1.35 | 4.62 | 11.12 | 10.69 |
Average Common Equity |
— | (0.25) | (0.08) | (0.32) | (1.25) | 0.97 | (2.68) |
Columns are period end dates